Harmful Effects of E-cigarettes on Health in Argentina

Regulations by 2FIRSTS.ai
Dec.26.2023
Harmful Effects of E-cigarettes on Health in Argentina
According to El Marplatense, despite the ban on e-cigarettes in Argentina, their use remains prevalent and harmful.

According to a report by El Marplatense on December 25th, the Argentine National Medicines Administration (ANMAT) has forbidden the importation, distribution, sale, and promotion of e-cigarettes since 2011. However, the use of e-cigarettes is firmly established among smokers who believe it to be a healthier alternative to traditional smoking.

 

Health expert Fortina, in an interview with UPM on Mitre Mar del Plata radio station, details that originally, e-cigarettes were used as a supplement for smoking cessation until smokers kicked the habit. "However, people have been using e-cigarettes continuously, and of course, it is just as harmful as smoking. It can cause cardiovascular events, lung damage, high blood pressure, severe pneumonia accompanied by respiratory failure, and even death. It can also trigger oral, mouth, and throat cancers."

 

Experts explain that, "There are some very important aspects in smoking cessation treatment, one of which is addiction itself, mediated by neurotransmitters, which are chemical substances in our brain that have a continuous supply-demand relationship. In this vicious cycle, it demands from you, gives you a sense of satisfaction, and then demands again. Another very important part is the behavioral aspect, such as what you hold in your hand, smoking after dinner, smoking after getting in a car. These habits related to behavior must be addressed in a different way.

 

According to a study, 37% of adolescents in American middle schools have tried smoking e-cigarettes and marijuana-infused e-cigarettes. This proportion has seen a significant increase among teenagers, with more severe consequences for their well-being.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris Korea: IQOS ILUMA i “SELETTI” Limited Edition Sells Out in One Week; Prime Model Sells Out on Launch Day
Philip Morris Korea: IQOS ILUMA i “SELETTI” Limited Edition Sells Out in One Week; Prime Model Sells Out on Launch Day
Philip Morris Korea and Italian design brand SELETTI’s limited “IQOS ILUMA i × SELETTI” collection sold out within one week of launch, with the “Prime” model selling out on its first day of release.
Nov.11 by 2FIRSTS.ai
Teen Nicotine Use Surges in Pakistan as Flavoured Vapes Spread Rapidly
Teen Nicotine Use Surges in Pakistan as Flavoured Vapes Spread Rapidly
Pakistan is experiencing a sharp rise in nicotine use among teenagers, driven by widespread availability of flavoured vapes and e-cigarettes. Cheap, sweet-flavoured devices are easily accessible in major cities, and weak enforcement of age limits has enabled young users to adopt vaping at alarming rates. Activists warn that industry marketing falsely portrays e-cigarettes as “safer,” putting youth at risk of long-term addiction and serious health effects.
Nov.14 by 2FIRSTS.ai
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.
Nov.10
International Tobacco Companies Report Significant Growth in Nicotine Pouch Business, Highlighted in Quarterly Financial Reports
International Tobacco Companies Report Significant Growth in Nicotine Pouch Business, Highlighted in Quarterly Financial Reports
Five major companies report growth in nicotine pouch business as a common highlight in their financial reports.
Nov.14 by 2FIRSTS.ai
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.
Nov.07 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai